Microbial Products Market: Overview
The market size for Microbial Products was USD 183.2 billion in 2021, and it is projected to grow at a CAGR of 8.4 percent during the forecast period. The market is expanding due to the rising demand for dairy products, which is being supported by the food and additives industry. The market is expanding due to the manufacture of enzymes for food preservation, paper, and leather sectors. The production of more cost- and environmentally-friendly healthcare and agricultural products is being boosted using recombinant genetic technology.
The global market for microbial products is being driven in large part by the increase in demand for microbial products for clinical diagnostics products. In July 2019, DMC successfully obtained Series equity financing with Sofinnova Partners' backing. The first will use its technologies to hasten development while simultaneously reducing biological complexity. As a result, a low-cost, fermentation-based manufacturing platform with the capacity to produce various microbial products will be created.
The growing demand for microbial products in the pharmaceutical industry is one of the main factors fueling growth in the microbial product market. The pharmaceutical sector has a lot of room for microbiology. The production of vaccines, antibiotics, insulin, and steroids heavily relies on using microorganisms and developing goods based on microbes. Vaccines are created using toxins, surface proteins, or killed or weakened microbes. The demand for microbial products among pharmaceutical research laboratories is being driven by the rising emphasis on research for the creation of novel antibiotic compounds, which is increasing the acceptance of new antibiotics by regulatory agencies, such as the US FDA and EMA. The numerous uses of microbial products in the pharmaceutical business are anticipated to fuel the market's expansion globally. The development of antibiotics resulting from microbial products is often quick and can be improved for higher production. For instance, in August 2020, Lonza increased the capacity of its Swiss production plant by 3,000 liters to meet the rising demand for microbial manufacturing solutions.
Microbial Products Market: COVID-19 Impact
Most of the manufacturing, developing, production, and logistical divisions in the market for microbial products have had a very difficult time due to the coronavirus epidemic. However, other sectors have experienced growth throughout this epidemic, and the market for microbial products is one of them. Although the growth of some businesses, such as agriculture, that are only loosely related to the microbial product industry has been drastically reduced, the microbial product market is still showing remarkable growth in the Covid-19 period. The market for microbial products is expanding significantly because everyone wants to use healthy and organic items in their homes and because there is an increasing need for biopesticides to protect foods and grains from pesticides.
Microbial Products Market: Drivers
Increased Use of Microbial Products in Agriculture Sector to Drive Market Growth
The industry grew due to the expanding trend of organic farming, which aims to reduce negative environmental effects and promote sustainability. The need for agricultural microbials is projected to be supported by the rising potential of organic farming techniques. It is also projected that this factor will drive up demand for crop protection products and natural plant growth regulators in the upcoming years. According to the National Agricultural Statistics Service's 2019 Organic Survey, the number of certified organic farms in the U.S. increased by 17% between 2016 and 2019. The adoption of organic farming has been strongly pushed by several governments, which has improved the product's appeal on a global scale. Leading companies and other governmental and non-governmental organizations promote sustainable agricultural methods by offering financial aid and subsidies for agricultural microbes, which are essential to such methods.
Technological Advancements made in Microbial Products Market to Drive Market Growth
The novel advancements in molecular biology and genetics enable scientists and researchers to develop new probiotic formulas that are more adaptable for animals. There is no question that microbial products benefit animal development and gut health. Throughout the projection period, the market for animal feeds would benefit from advancing new-age innovation, providing improved prospects. Over the past few decades, the market for microbial products has grown significantly due to the rapid improvement of science and technology. These days, the market has seen the introduction of animal-specific feeds that vary in dosages and microbiological content based on the type of animal (canine, poultry, etc.). After the Food and Drug Administration (FDA) published its Guidance for Industry 213 and Veterinary Feed Directive, the situation regarding cow feed changed. The FDA's approach has changed the overall feeding environment, albeit having a minimal impact on cattle output.
Microbial Products Market: Restraints
Difficulties Related to the Manufacturing and Formulation of Microbial Products to Hamper Market Growth
The market for microbial products will face significant challenges throughout the projected period due to issues with production and formulation. Microphone makers frequently face difficult problems when considering clinical developments, manufacturing, and technology. Vendors' difficulties in manufacturing and formulation operations are producing stable engraftments. Other difficulties include finding pertinent biosensors, creating strong gene circuits, upholding safety and bio-contentment standards, and effectively designing microbial therapies. By delaying the creation of microbial products during ordinary operations, barriers are put in the way of the market's rapid expansion on a global scale.
Microbial Products Market: Segment Overview
Bacterial Sector to Dominate Market Owing to its Increased Use in Research Facilities
The bacterial segment is anticipated to lead the microbial product market during the forecast year. In research facilities and industrial settings, bacteria cultures are frequently used. These include methicillin-resistant/sensitive research materials, quality control organisms for commercial identification systems, extremophile strains from various environmental sources, and genomic DNA from well-characterized microbial strains suitable for amplification by PCR technique. Additionally, different bacterial species, anaerobic bacteria, and bacterial genome sequencing strains are other techniques and culture methods used by various industries for their research and development purposes and are anticipated to drive the market in the future. The production of a wide range of chemicals, including esters, fragrance compounds, and active substances often used in household and personal care products, has been directly or indirectly linked to numerous living molecules, including bacteria. Bacteria are one of the microbes utilized in the production of home and personal care products because they emit many physiologically active compounds with high commercial value, such as oligosaccharides, biosurfactants, exopolysaccharides (EPS), peptides, enzymes, and vitamins.
Biotechnology Category to Dominate the Market Owing to Increased Yield of Microbial Products
In terms of application, the biotechnology segment dominates the microbial product market. Biotechnology is the application of biological organisms to technological processes. The dominance of the biotechnology category can be attributed to the high level of engineering utilized in biotechnology to increase the yield of microbial products utilizing several techniques, such as introducing mutations into an organism and gene amplifying plasmids. Because of their extensive variety of metabolic potentials and well-established manipulation techniques, microbes are regarded as outstanding biological materials for biotechnology. Industrial processes involving pure cultures of bacteria are used to create alcohols, organic acids, and polymeric chemicals.
Microbial Products Market: Regional Landscape
North America to Dominate Market due to Rising Importance of Microbe-based Clinical Research
Over the forecast period, it is anticipated that the North American market will account for the largest revenue share. The significant regional expenditure on healthcare, the strong reimbursement policies, and the high insurance penetration contribute to the market's growth. Additionally, the high per capita income in the region and the high per capita use of microbiological products contribute to the regional market's expansion. The US and Canada are the two biggest markets in North America for microbiological products. The expansion of the microbial product market in North America over the forecast period would be aided by the rising importance of microbe-based clinical research and the rising prevalence of new infectious illnesses. In December 2021, Scientific Industries, Inc., a provider of life sciences tools and creator of digitally simplified bioprocessing products, announced Scientific Bioprocessing, Inc. (SBI) had signed an exclusive partnership with BioMADE to offer transformative learning opportunities and cutting-edge tools to college students across the US. The newest Manufacturing Innovation Institute focused on expanding bio-industrial manufacturing across the country is called made.
The European market is anticipated to experience stable revenue growth throughout the forecast period. UK, Germany, and France are included in this region. They can be used to protect plants since some bacteria, fungus, viruses, and protozoa are parasites or pathogens of insects, other pests, or harmful creatures. Due to their biological traits, these microorganisms are utilized worldwide (including in the EU) in the biological management of pests and plant diseases. In light of this, the market in this area may benefit from the increasing use of such items. Government agencies across Europe are currently putting into effect legislative directives to reduce reliance on pesticides in agriculture to promote consumer and environmental safety and use microbial products, which is driving the growth of the microbial product market. As of 2019, the country had about 30,000 organic farms, according to BLW (Organic Food Production Alliance). Approximately 10% of all agricultural enterprises fall under this category. A further 30,000 to 40,000 farmers would need to switch to organic farming to meet the government's goal.
Global Microbial Products Market: Competitive Landscape
In April 2020, Sumitomo Chemicals invested USD 30 million in a joint venture with Conagen, a biotechnology company headquartered in the US. The corporation wanted to take advantage of this chance to boost its strategic business partnership with Conagen while also creating new, high-function products and procedures by utilizing biologicals in fresh and inventive ways. Sumitomo Chemicals Company successfully acquired four South American subsidiaries of Nufarm Limited — one in Brazil, Argentina, Chile, and Colombia to broaden its global foothold in the crop protection industry across numerous continents. Similarly, in June 2019, Bayer and Alpha bio entered into a partnership agreement to commercialize flipper, a biological pest management product. Additionally, Bayer has a worldwide exclusive license from Alpha Bio to market flippers for agricultural and non-agricultural uses through this deal.
Few of the Microbial Products Market players include Amgen Inc., Merck & Co. Inc., VALENT Biosciences Corp., GlaxoSmithKline plc., Pfizer Inc., BIOMÉRIEUX SA, Ajinomoto Co. Inc., SANOFI S.A, Novartis AG, NOVADIGM Therapeutics and Kyowa Hakko Bio Co. Ltd.
Global Microbial Products Market is Segmented as Below:
By End Users
Key Elements Included In The Study: Global Microbial Products Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Under uncertainty, traditional approaches to strategic planning can be downright dangerous. True ambiguity is no basis to forecast the future – degree of risk, the magnitude of circumstances, conditions and consequences are not known or unpredictable. To avoid dangerous binary views of uncertainty; strategic posture, moves and actions through market research is the best bet.Read more